Sunovion Pharmaceuticals announces availability of Aptiom
MARLBOROUGH, Mass. — Sunovion Pharmaceuticals on Monday announced that Aptiom (eslicarbazepine acetate), a once-daily antiepileptic drug, is now available across the United States.
The drug, which received approval from the Food and Drug Administration on Nov. 8, 2013, is a prescription medicine used with other medicines to treat partial-onset seizures. The drug is available in four table strengths: 200 mg, 400 mg, 600 mg and 800 mg; it can be taken whole or crushed, with food or without.
“Epilepsy is a serious condition that not only affects the people who suffer from seizures, but also their family, caregivers and friends,” said Michael R. Sperling, M.D., professor of neurology at Thomas Jefferson University and director of the Jefferson Comprehensive Epilepsy Center in Philadelphia. “Approximately one-third of those with epilepsy still have inadequate seizure control despite treatment, so we need new therapies. Aptiom is a welcome addition to our therapeutic toolkit that may help some patients.”
Epilepsy is one of the most common neurological disorders and affects nearly 2.2 million people in the United States, the company said. Partial-onset seizures are the most prevalent type of seizure and are connected with 60% of new epilepsy diagnoses.
Upsher-Smith, Hamacher Resource Group launch first in e-book series for independent pharmacists
WAUKESHA, Wis. — Upsher-Smith has announced the release of the first in a series of educational e-books authored by Hamacher Resource Group and created for independent community pharmacists.
The first e-book in the series is “Community Pharmacy: Foundation for the Future,” and was developed to assist independent pharmacists/owners with assessing the state of their business and preparing strategies for continued growth.
Upsher-Smith collaborated with HRG to develop the series because of its 30-plus years serving independent pharmacy and objective position in the industry.
“We have worked with HRG for a number of years and were confident that their expertise in independent pharmacy would lead to insightful content and practical exercises that pharmacists could use to enhance their plans for the future of their pharmacy,” stated Scott Hussey, SVP, commercial operations at Upsher-Smith.
Independent pharmacists/owners interested in downloading a copy of “Community Pharmacy: Foundation for the Future,” can visit Hamacher.com/FoundationForTheFuture. There is also an email link to Upsher-Smith on the page that pharmacists can use to provide feedback about the book, as well as suggest topics for future e-books.
“This was a very enjoyable project for us and we were thrilled to put some of our acquired knowledge into a concise, digestible format to help independent pharmacists prepare for future success,” stated Dave Wendland, HRG VP and member of the owners group. ”We’re looking forward to collaborating with Upsher-Smith on the remaining e-books in the series and hope to release the second and third books before the end of the year.”
Rite Aid awarded Specialty Pharmacy accreditation from URAC
CAMP HILL, Pa. — Rite Aid on Tuesday announced it has been awarded Specialty Pharmacy accreditation from URAC, a Washington, D.C.-based healthcare accreditation organization that establishes quality standards for the healthcare industry.
“We are very proud to have received full accreditation as a specialty pharmacy provider from URAC,” stated Robert Thompson, Rite Aid EVP pharmacy. “Every day, Rite Aid pharmacists are committed to providing all of our patients, especially those receiving specialty pharmacy treatments, with the best care possible. This designation from URAC recognizes our efforts and is great achievement for our Specialty Pharmacy team.”
With FDA approval of more and more complex medication therapies, Rite Aid believes it is critical to have the processes in place to support these therapies and the clinical care programs to promote positive outcomes for patients. Rite Aid Specialty Pharmacy achieves this through individualized patient care plans, disease and drug education and ongoing adherence management.
“By applying for and receiving URAC accreditation, Rite Aid has demonstrated a commitment to quality healthcare,” commented URAC president and CEO Kylanne Green. “In today’s healthcare market, URAC accreditation provides a mark of distinction and we applaud Rite Aid for meeting strict quality standards and achieving URAC Specialty Pharmacy accreditation.”